Abstract
Introduction
Primary mitochondrial disease is caused by either mitochondrial or nuclear DNA mutations that impact the function of the mitochondrial respiratory chain. Individuals with mitochondrial disorders have comorbid conditions that may increase their risk for poor bone health. The objective of this retrospective electronic medical record (EMR) review was to examine risk factors for poor bone health in children and adults with primary mitochondrial disease.
Methods
Eighty individuals with confirmed clinical and genetic diagnoses of primary mitochondrial disease at the Children’s Hospital of Philadelphia (CHOP) were included in this study. Risk factors and bone health outcomes were collected systematically, including: anthropometrics (low BMI), risk-conferring co-morbidities and medications, vitamin D status, nutrition, immobility, fracture history, and, where available, dual energy x-ray absorptiometry (DXA) bone mineral density (BMD) results.
Results
Of patients 73% (n = 58) had at least one risk factor and 30% (n = 24) had four or more risk factors for poor bone health. The median number of risk factors per participant was 2, with an interquartile interval (IQI 0–4). In the subset of the cohort who were known to have sustained any lifetime fracture (n = 11), a total of 16 fractures were reported, six of which were fragility fractures, indicative of a clinically significant decrease in bone strength.
Conclusions
The prevalence of risk factors for poor bone health in primary mitochondrial disease is high. As part of supportive care, practitioners should address modifiable risk factors to optimize bone health, and have a low threshold to evaluate clinical symptoms that could suggest occult fragility fracture.
Similar content being viewed by others
References
Alexandru D, So W (2012) Evaluation and management of vertebral compression fractures. Perm J 16(4):46–51
Barry DW, Kohrt WM (2008) Exercise and the preservation of bone health. J Cardiopulm Rehabil Prev 28(3):153–162
Bishop N et al (2014) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 pediatric official positions. J Clin Densitom 17(2):275–280
Chinnery PF (1993) Mitochondrial disorders overview. In: Pagon RA et al (ed) GeneReviews(R). University of Washington, Seattle
Cholley F et al (2001) Mitochondrial respiratory chain deficiency revealed by hypothermia. Neuropediatrics 32(2):104–106
De Block CE et al (2004) A novel 7301-bp deletion in mitochondrial DNA in a patient with Kearns-Sayre syndrome, diabetes mellitus, and primary amenorrhoea. Exp Clin Endocrinol Diabetes 112(2):80–83
Dobson PF et al (2016) Unique quadruple immunofluorescence assay demonstrates mitochondrial respiratory chain dysfunction in osteoblasts of aged and PolgA(−/−) mice. Sci Rep 6:31907
Dosa NP et al (2007) Incidence, prevalence, and characteristics of fractures in children, adolescents, and adults with spina bifida. J Spinal Cord Med 30(Suppl 1):S5–S9
Drezner MK (2004) Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 5(Suppl 2):S41–S47
Eigentler A et al (2014) Low bone mineral density in Friedreich ataxia. Cerebellum 13(5):549–557
Fedorenko M, Wagner ML, Wu BY (2015) Survey of risk factors for osteoporosis and osteoprotective behaviors among patients with epilepsy. Epilepsy Behav 45:217–222
Gordon CM et al (2014) 2013 pediatric position development conference: executive summary and reflections. J Clin Densitom 17(2):219–224
Grieff M, Bushinsky DA (2011) Diuretics and disorders of calcium homeostasis. Semin Nephrol 31(6):535–541
Harvey JN, Barnett D (1992) Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol 37(1):97–103
Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930
Kalkwarf HJ et al (2007) The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 92(6):2087–2099
Kanis JA et al (1994) The diagnosis of osteoporosis. J Bone Miner Res 9(8):1137–1141
Khan TS, Fraser LA (2015) Type 1 diabetes and osteoporosis: from molecular pathways to bone phenotype. J Osteoporos 2015:174186
Kuczmarski RJ et al (2000) CDC growth charts: United States. Adv Data 314:1–27
Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL (2002) 2000 CDC Growth Charts for the United States: methods and development. Vital and Health Statistics Series 11, Data from the National Health Survey (246):1–190
Lewiecki EM et al (2016) Best practices for dual-energy X-ray absorptiometry measurement and reporting: International Society for Clinical Densitometry Guidance. J Clin Densitom 19(2):127–140
Lindsey RC, Mohan S (2016) Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Mol Cell Endocrinol 432:44–55
Mazziotti G et al (2016) Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines. Endocrine doi:10.1007/s12020-016-1146-8
McDonald DG et al (2002) Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 44(10):695–698
Mirza F, Canalis E (2015) Management of endocrine disease: secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 173(3):R131–R151
Misra M et al (2008) Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122(2):398–417
Miyazaki T et al (2003) Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J Cell Biol 160(5):709–718
Murphy JL et al (2008) Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 131(Pt 11):2832–2840
O’Flynn N (2012) Risk assessment of fragility fracture: NICE guideline. Br J Gen Pract 62(605):667–668
Panday K, Gona A, Humphrey MB (2014) Medication-induced osteoporosis: screening and treatment strategies. Ther Adv Musculoskelet Dis 6(5):185–202
Papiha SS et al (1998) Age related somatic mitochondrial DNA deletions in bone. J Clin Pathol 51(2):117–120
Parikh S et al (2015) Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial Medicine Society. Genet Med 17(9):689–701
Pavlovic A et al (2013) Relationship of thoracic kyphosis and lumbar lordosis to bone mineral density in women. Osteoporos Int 24(8):2269–2273
Sadat-Ali M et al (2008) Does scoliosis causes low bone mass? A comparative study between siblings. Eur Spine J 17(7):944–947
Schaefer AM et al (2013) Endocrine disorders in mitochondrial disease. Mol Cell Endocrinol 379(1–2):2–11
Shiek Ahmad B et al (2016) Bone mineral changes in epilepsy patients during initial years of antiepileptic drug therapy. J Clin Densitom doi:10.1016/j.jocd.2016.07.008.
Sinha A et al (2013) Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab 98(3):E509–E513
Stacpoole PW et al (2012) Design and implementation of the first randomized controlled trial of coenzyme CoQ(1)(0) in children with primary mitochondrial diseases. Mitochondrion 12(6):623–629
Sunyecz JA (2008) The use of calcium and vitamin D in the management of osteoporosis. Ther Clin Risk Manag 4(4):827–836
Toth M, Grossman A (2013) Glucocorticoid-induced osteoporosis: lessons from Cushing’s syndrome. Clin Endocrinol 79(1):1–11
Trifunovic A et al (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429(6990):417–423
Tzoufi M et al (2013) A rare case report of simultaneous presentation of myopathy, Addison’s disease, primary hypoparathyroidism, and Fanconi syndrome in a child diagnosed with Kearns-Sayre syndrome. Eur J Pediatr 172(4):557–561
Varanasi SS et al (1999) Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int 10(2):143–149
Weaver CM et al (2016) The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int 27(4):1281–1386
Weber DR et al (2015) Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using the health improvement network (THIN). Diabetes Care 38(10):1913–1920
Weger M et al (1999) Incomplete renal tubular acidosis in ‘primary’ osteoporosis. Osteoporos Int 10(4):325–329
Wei SH, Lee WT (2015) Comorbidity of childhood epilepsy. J Formos Med Assoc 114(11):1031–1038
Whittaker RG et al (2007) Prevalence and progression of diabetes in mitochondrial disease. Diabetologia 50(10):2085–2089
Zemel BS et al (2010) Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95(3):1265–1273
Zemel BS et al (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96(10):3160–3169
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Details of funding
The funding for this observational study was provided by NIH K23DK102659, (SEM).
Ethical guidelines
This study has been approved by the CHOP IRB, and was conducted in accordance with the principles of the Declaration of Helsinki of 1975 as revised in 2000. All written informed consent was obtained from patients and/or guardians, as appropriate.
Additional information
Communicated by: Daniela Karall
Electronic supplementary material
Supplemental Fig. 1
(DOCX 33 kb)
Supplemental Table 1
(DOCX 23 kb)
Supplemental Table 2
(DOCX 23 kb)
Supplemental Table 3
(DOCX 23 kb)
Supplemental Table 4
(DOCX 23 kb)
Supplemental Table 5
(DOCX 27 kb)
Rights and permissions
About this article
Cite this article
Gandhi, S.S., Muraresku, C., McCormick, E.M. et al. Risk factors for poor bone health in primary mitochondrial disease. J Inherit Metab Dis 40, 673–683 (2017). https://doi.org/10.1007/s10545-017-0046-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-017-0046-2